Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel

The management of dyslipidemias constitutes a key target in decreasing the risk of morbidity and mortality among patients after acute coronary syndrome (ACS)1,2. Both the 2018 American College of Cardiology/American Heart Association / Multi-society (2018 ACA/AHA/MS) Guidelines and the European Society of Cardiology (ESC) Dyslipidemia Guidelines consider individuals with established coronary artery disease at high risk for future cardiovascular events and recommend intensive lipid-lowering strategies for them3,4.
Source: Journal of Clinical Lipidology - Category: Lipidology Authors: Tags: Original Research Source Type: research